Assessing Vulnerability to COVID-19 in High-Risk Populations: The Role of SARS-CoV-2 Spike-Targeted Serology
View ORCID ProfileHarvey W Kaufman, William A Meyer III, Nigel J Clarke, Jeff Radcliff, Christopher M Rank, James Freeman, Marcia Eisenberg, Laura Gillim, William G Morice, David M Briscoe, David S Perlin, Jay G Wohlgemuth
doi: https://doi.org/10.1101/2022.08.22.22279079
Harvey W Kaufman
1Quest Diagnostics, 500 Plaza Drive, Secaucus, NJ 07940
MDWilliam A Meyer III
1Quest Diagnostics, 500 Plaza Drive, Secaucus, NJ 07940
PhDNigel J Clarke
1Quest Diagnostics, 500 Plaza Drive, Secaucus, NJ 07940
PhDJeff Radcliff
1Quest Diagnostics, 500 Plaza Drive, Secaucus, NJ 07940
BSChristopher M Rank
2Roche Diagnostics Nonnenwald 2, 82377 GmbH, Penzberg, Germany
PhDJames Freeman
3Siemens Healthineers, 511 Benedict Ave, Tarrytown, New York 10591
BSMarcia Eisenberg
4LabCorp, 531 South Spring Street Burlington, NC 27215
PhDLaura Gillim
4LabCorp, 531 South Spring Street Burlington, NC 27215
PhDWilliam G Morice
5Mayo Medical Laboratories, 3050 Superior Dr., NW Rochester, MN, 55905
MD, PhDDavid M Briscoe
6Boston Children’s Hospital, 300 Longwood Ave., Boston, MA 02115
MDDavid S Perlin
7Center for Discovery and Innovation, Hackensack Meridian Health, 111 Ideation Way, Nutley, NJ 07110
PhDJay G Wohlgemuth
1Quest Diagnostics, 500 Plaza Drive, Secaucus, NJ 07940
MDData Availability
All data produced in the present work are contained in the manuscript
Data Availability
All data produced in the present work are contained in the manuscript
Posted August 23, 2022.
Assessing Vulnerability to COVID-19 in High-Risk Populations: The Role of SARS-CoV-2 Spike-Targeted Serology
Harvey W Kaufman, William A Meyer III, Nigel J Clarke, Jeff Radcliff, Christopher M Rank, James Freeman, Marcia Eisenberg, Laura Gillim, William G Morice, David M Briscoe, David S Perlin, Jay G Wohlgemuth
medRxiv 2022.08.22.22279079; doi: https://doi.org/10.1101/2022.08.22.22279079
Assessing Vulnerability to COVID-19 in High-Risk Populations: The Role of SARS-CoV-2 Spike-Targeted Serology
Harvey W Kaufman, William A Meyer III, Nigel J Clarke, Jeff Radcliff, Christopher M Rank, James Freeman, Marcia Eisenberg, Laura Gillim, William G Morice, David M Briscoe, David S Perlin, Jay G Wohlgemuth
medRxiv 2022.08.22.22279079; doi: https://doi.org/10.1101/2022.08.22.22279079
Subject Area
Subject Areas
- Addiction Medicine (398)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2911)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12687)
- Forensic Medicine (10)
- Gastroenterology (825)
- Genetic and Genomic Medicine (4547)
- Geriatric Medicine (413)
- Health Economics (723)
- Health Informatics (2901)
- Health Policy (1067)
- Hematology (383)
- HIV/AIDS (920)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4313)
- Nursing (233)
- Nutrition (634)
- Oncology (2253)
- Ophthalmology (642)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (277)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1193)
- Primary Care Research (492)
- Public and Global Health (6901)
- Radiology and Imaging (1520)
- Respiratory Medicine (913)
- Rheumatology (435)
- Sports Medicine (381)
- Surgery (483)
- Toxicology (60)
- Transplantation (209)
- Urology (178)